Parkside Financial Bank & Trust »

Bioxcel Therapeutics shares owned by Parkside Financial Bank & Trust

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Parkside Financial Bank & Trust from 13F filings

Historical chart of Parkside Financial Bank & Trust investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Parkside Financial Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Parkside Financial Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1k 1.8k 0.61

More positions owned by Parkside Financial Bank & Trust

Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Val Etf (IWD)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Bd Index Fds Intermed Term (BIV)
Spdr S&p 500 Etf Tr Put Put Option (Principal) (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)

View all positions for Parkside Financial Bank & Trust

Top funds holding Bioxcel Therapeutics

Armistice Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Wells Fargo & Company
Renaissance Technologies
State Street Corporation
Morgan Stanley
Goldman Sachs Group
Bank of America Corporation
Citadel Advisors
Jane Street
Susquehanna International
Bnp Paribas Arbitrage, Snc

View all funds holding Bioxcel Therapeutics